Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mulligan

Showing results (221-230 of 245) with videos related to

Pageof 25
Sort By:
Blood|April 14, 2005
Conservation of unique cell-surface CD antigen mosaics in HIV-1-infected individualsAdrian Woolfson, Justin Stebbing, Brian D M Tom, et al.
The Journal of Clinical Endocrinology and Metabolism|August 9, 2019
Intramyocardial Triglycerides Among Women With vs Without HIV: Hormonal Correlates and Functional ConsequencesMabel Toribio, Tomas G Neilan, Magid Awadalla, et al.
Blood|October 7, 2022
Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversionYandong Shen, Jane A Freeman, Juliette Holland, et al.
Blood|March 2, 2026
Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trialJeff P Sharman, Luca Laurenti, Emmanuelle France Ferrant, et al.
Blood|November 21, 2018
Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximabAnton W Langerak, Matthias Ritgen, Valentin Goede, et al.
The Journal of Infectious Diseases|May 18, 2019
Immune Correlates of Diffuse Myocardial Fibrosis and Diastolic Dysfunction Among Aging Women With Human Immunodeficiency VirusMarkella V Zanni, Magid Awadalla, Mabel Toribio, et al.
American Journal of Hematology|September 13, 2019
Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphomaTalha Munir, Jennifer R Brown, Susan O'Brien, et al.
Leukemia|June 25, 2021
Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendationsWilliam G Wierda, Andrew Rawstron, Florence Cymbalista, et al.
The Lancet. Oncology|May 15, 2016
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 studyStephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig, et al.
Plos One|August 4, 2023
Amygdalar activity measured using FDG-PET/CT at head and neck cancer staging independently predicts survivalMalek Z O Hassan, Ahmed Tawakol, Ying Wang, et al.
Pageof 25

Showing results (221-230 of 245) with videos related to

Sort By:
Pageof 25
Blood|April 14, 2005
Conservation of unique cell-surface CD antigen mosaics in HIV-1-infected individualsAdrian Woolfson, Justin Stebbing, Brian D M Tom, et al.
The Journal of Clinical Endocrinology and Metabolism|August 9, 2019
Intramyocardial Triglycerides Among Women With vs Without HIV: Hormonal Correlates and Functional ConsequencesMabel Toribio, Tomas G Neilan, Magid Awadalla, et al.
Blood|October 7, 2022
Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversionYandong Shen, Jane A Freeman, Juliette Holland, et al.
Blood|March 2, 2026
Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trialJeff P Sharman, Luca Laurenti, Emmanuelle France Ferrant, et al.
Blood|November 21, 2018
Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximabAnton W Langerak, Matthias Ritgen, Valentin Goede, et al.
The Journal of Infectious Diseases|May 18, 2019
Immune Correlates of Diffuse Myocardial Fibrosis and Diastolic Dysfunction Among Aging Women With Human Immunodeficiency VirusMarkella V Zanni, Magid Awadalla, Mabel Toribio, et al.
American Journal of Hematology|September 13, 2019
Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphomaTalha Munir, Jennifer R Brown, Susan O'Brien, et al.
Leukemia|June 25, 2021
Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendationsWilliam G Wierda, Andrew Rawstron, Florence Cymbalista, et al.
The Lancet. Oncology|May 15, 2016
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 studyStephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig, et al.
Plos One|August 4, 2023
Amygdalar activity measured using FDG-PET/CT at head and neck cancer staging independently predicts survivalMalek Z O Hassan, Ahmed Tawakol, Ying Wang, et al.
Pageof 25